News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2018 Shelley Wood October 02, 2018
News Conference News PREPARE-CALC Shows Benefits of Rotational Atherectomy TCT Daily Staff October 01, 2018
News Daily News Add-on Payment Now in Effect for Sentinel Protection Device During TAVR Todd Neale October 01, 2018
News Conference News TCT 2018 ‘Enabling Strategies’ Improve Success of Chronic Total Occlusion PCI TCT Daily Staff September 28, 2018
News Conference News TCT 2018 Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR TCT Daily Staff September 28, 2018
News Conference News TCT 2018 PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience L.A. McKeown September 27, 2018
News Conference News TCT 2018 CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD Shelley Wood September 26, 2018
News Conference News TCT 2018 RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation Todd Neale September 26, 2018
Presentation TCT Abstracts Posters 2018 Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation Presenter: Hyungdon Kook September 25, 2018
News Conference News TCT 2018 Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials Michael O'Riordan September 25, 2018
News Conference News TCT 2018 NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days Yael L. Maxwell September 25, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap! Shelley Wood September 25, 2018
Presentation TCT 2018 RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease Presenter: James B. Hermiller Jr, Hiroki Shiomi September 25, 2018
News Conference News TCT 2018 PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes Michael O'Riordan September 25, 2018
Presentation TCT 2018 COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions Presenter: Felix Mahfoud, Patrick W. Serruys, Pieter C. Smits September 25, 2018
Presentation TCT Abstracts Posters 2018 Drug transfer to the vessel wall by drug-coated hyper-compliant balloon catheters (DCHCB) Presenter: Maciej Kusmierczuk September 25, 2018
Presentation TCT Abstracts Posters 2018 Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents Presenter: Woo-Young Chung September 25, 2018
Presentation Drug transfer to the vessel wall by drug-coated hyper-compliant balloon catheters (DCHCB) Presenter: Maciej Kusmierczuk September 25, 2018
Presentation TCT Abstracts Posters 2018 Characterization of Long-Term Mechanical Interaction Between a Bioresorbable Scaffold and Coronary Lesion Throughout Two Years of Scaffold Degradation Presenter: Tanya Qiu September 25, 2018